Enveric Biosciences (ENVB) EBITDA Margin (2014 - 2025)
Enveric Biosciences (ENVB) recorded EBITDA Margin of 0.78% in Q3 2020, up 11.75 percentage points from -10.96% a year earlier and up 3.61 percentage points from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) EBITDA Margin (2014 - 2025) Analysis & Trends
On a TTM basis, Enveric Biosciences' EBITDA Margin came in at 6.15% as of Sep 30, 2020, up 37.31 percentage points year-over-year; for FY2019, it came in at -0.08%, up 9.79 percentage points from FY2018.
- Annual EBITDA Margin has a four-year change of +3.02 percentage points (FY2015 to FY2019).
- Across earlier years, EBITDA Margin came in at -9.87% in FY2018 (+5.94 pp), -15.80% in FY2017 (-4.69 pp), -11.12% in FY2016 (-8.02 pp) and -3.10% in FY2015.
- Quarterly EBITDA Margin has ranged from -98.84% in Q4 2018 to 63.70% in Q3 2018 over the past five years.
- On a year-over-year basis, EBITDA Margin has increased for four consecutive quarters, with an average year-over-year change of -1.50 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 127.77 percentage points in Q4 2019, against a drop of 78.52 percentage points in Q4 2018 at the low end.
- Per Business Quant, the preceding three quarters came in at -2.83% (Q2 2020), -2.89% (Q1 2020) and 28.94% (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Enveric Biosciences | 6.02 Mn | -15.62 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -669,187.59% |
| Mar 31, 2025 | -64,775.80% |
| Jun 30, 2024 | -3,489.18% |
| Mar 31, 2024 | -5,177.74% |
| Dec 31, 2023 | -406,303.53% |
| Sep 30, 2023 | -150,294.99% |
| Jun 30, 2023 | -618,830.68% |
| Sep 30, 2020 | 1.21% |
| Jun 30, 2020 | -2.83% |
| Mar 31, 2020 | -2.89% |
| Dec 31, 2019 | 28.94% |
| Sep 30, 2019 | -10.96% |
| Jun 30, 2019 | -8.30% |
| Mar 31, 2019 | -6.90% |
| Dec 31, 2018 | -98.84% |
| Sep 30, 2018 | 63.70% |
| Jun 30, 2018 | -2.44% |
| Mar 31, 2018 | -4.94% |
| Dec 31, 2017 | -20.32% |
| Sep 30, 2017 | -24.97% |
API Access
Enveric Biosciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();